Publications by authors named "Evelyn Santiago"

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder developing from multiple aetiologies with overlapping pathophysiological mechanisms. HFpEF diagnosis may be challenging, as neither cardiac imaging nor physical examination are sensitive in this situation. Here, we review biomarkers of HFpEF, of which the best supported are related to myocardial stretch and injury, including natriuretic peptides and cardiac troponins.

View Article and Find Full Text PDF
Article Synopsis
  • Obesity is linked to better survival outcomes in heart failure patients regardless of LVEF classification (HFrEF, HFmrEF, HFpEF), particularly for those classified as mildly obese.
  • The study analyzed 5,155 patients from Italy and Spain, showing that mild obesity correlated with lower all-cause mortality rates across varying heart failure types, except for ischaemic cases.
  • The findings suggest that while mild obesity benefits prognosis in heart failure, this advantage predominantly applies to non-ischaemic heart failure patients.
View Article and Find Full Text PDF

Heart failure (HF) is a major public health problem and a leading cause of hospitalization in western countries. Over the past decades, the goal has been to find the best method for monitoring congestive symptoms to prevent hospitalizations. Addressing this task through regular physician visits, blood tests, and imaging has proven insufficient for optimal control and has not decreased enough HF-related hospitalization rates.

View Article and Find Full Text PDF
Article Synopsis
  • Heart transplantation (HT) is the preferred treatment for advanced heart failure, and the study aimed to analyze the costs associated with both emergency and elective HT procedures in a hospital setting.
  • The average cost for HT was found to be €62,203, with elective procedures costing significantly less (about €47,540) compared to emergency procedures (about €102,733), largely due to longer hospital stays and increased medication expenses for emergency cases.
  • Despite the higher costs, elective HT had a much better survival rate (96%) compared to emergency HT (68%), suggesting a need for better management strategies for patients with heart failure to prevent the necessity for emergency transplants.
View Article and Find Full Text PDF

There is scarce evidence for pulmonary artery denervation (PADN) as a potential treatment for chronic postcapillary pulmonary hypertension (PH). We aimed to perform a proof-of-concept of PADN in a translational model of chronic PH. Nineteen pigs with chronic postcapillary PH (secondary to pulmonary vein banding) were randomized to surgical-PADN (using bipolar radiofrequency clamps) or sham procedure.

View Article and Find Full Text PDF

Background: Chronic obstructive pulmonary disease and heart failure (HF) are 2 diseases with high morbidity and mortality. The coexistence of these two diseases is estimated to be frequent, but has been poorly studied.

Aim: To study the prevalence of airflow limitation in a sample of patients diagnosed with HF in follow-up in an HF unit and to assess their characteristics and comorbidities.

View Article and Find Full Text PDF

Background: Renal replacement therapy (RRT) after heart transplant (HT) is associated with worse prognosis. We aimed to identify predictors of RRT and the impact of this complication on long-term survival.

Methods: Cohort study of HT patients.

View Article and Find Full Text PDF

Objectives: Moderate chronic renal insufficiency is often found in patients evaluated for heart transplant. Recovery of cardiac output after heart transplant might lead to improvement of renal function. In this study, our aim was to identify predictors of improvement of renal function after heart transplant.

View Article and Find Full Text PDF

Background: Pulmonary hypertension (PH) and right ventricular (RV) dysfunction are strong predictors of morbidity and mortality among patients with congenital heart disease. Early detection of RV involvement may be useful in the management of these patients. We aimed to assess progressive cardiac adaptation and quantify myocardial extracellular volume in an experimental porcine model of PH because of aorto-pulmonary shunt using cardiac magnetic resonance (CMR).

View Article and Find Full Text PDF
Article Synopsis
  • Beta-3 adrenergic receptor (β3AR) agonists have shown promise in treating pulmonary hypertension (PH) by promoting vasodilation and improving heart function.
  • In a study with pigs experiencing chronic PH, administration of β3AR agonists led to significant reductions in pulmonary vascular resistance (PVR) and enhancements in right ventricular (RV) performance over a two-week period.
  • The research indicated that β3AR agonists not only effectively reduce PVR but also improve RV function, suggesting their potential as a new treatment option for chronic PH in humans.
View Article and Find Full Text PDF

Background: Pulmonary hypertension (PH) and collagen metabolism abnormalities are prevalent in patients with heart failure with preserved ejection fraction (HFpEF). Peripheral endothelial dysfunction (PED) has been described in HF and in pulmonary arterial hypertension. Our aim is to determine whether PH is associated with PED and impaired collagen metabolism in patients with HFpEF.

View Article and Find Full Text PDF

Plasma cell dyscrasias are frequently associated with kidney disease through the production of monoclonal immunoglobulin but with a diverse set of pathologic renal patterns. While almost all patients with a renal biopsy showing a cast nephropathy have myeloma, kidney involvement associated with pathological immunoglobulin light chains and lymphoma is rare. To our knowledge, this is the first report of a cast nephropathy associated with lymphoplasmacytic lymphoma.

View Article and Find Full Text PDF